Please use a PC Browser to access Register-Tadawul
Get It
BioXcel Therapeutics shares are trading higher after the company announced that the Centers for Medicare & Medicaid Services issued a permanent and product-specific J-Code for IGALMI sublingual film.
Bioxcel Therapeutics BTAI | 1.92 | -5.42% |